U.K. Newco Raises £6 Mil. To Discover Ubiquitin-Targeting Cancer Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
Cancer-focused Mission Therapeutics attracts £6 million Series A, including corporate VC.
You may also be interested in...
Servier Research Deals Suggest Business-As-Usual For Scandal-Ridden Firm
Still reeling from the Mediator scandal, Servier's two latest cancer research deals suggest the French company is trying to move forward.
Servier Research Deals Suggest Business-As-Usual For Scandal-Ridden Firm
Still reeling from the Mediator scandal, Servier's two latest cancer research deals suggest the French company is trying to move forward.
Belgium's Amakem Raises €18 million In Europe's Largest Series A So Far In 2011
Belgian start-up raises record-breaking €18 million A round to take rho kinase inhibitor glaucoma candidate to clinical proof-of-concept.